Drug Discovery Informatics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow, Service, Solution, End User, and Geography

Description

List of Tables

The global drug discovery informatics Market was valued at US$ 3.39 billion in 2024 and is expected to reach US$ 8.17 billion by 2031. The Drug Discovery Informatics market size is estimated to register a CAGR of 13.7% during 2025-2031.

The global drug discovery informatics market is expected to grow significantly during the forecast period, driven by increasing R&D activities, demand for targeted therapies, and technological advancements in data analytics. Countries such as the United States, Germany, Japan, and China are leading this shift, propelled by the need for faster drug development, improved accuracy in drug screening, and reduced research costs. The integration of AI and machine learning into Drug Discovery Informatics platforms is enabling real-time analysis of biological and chemical data, enhancing decision-making and productivity across the drug discovery pipeline.

Pharmaceutical companies are leveraging drug discovery informatics for hit identification, lead optimization, and predictive modeling, which supports quicker identification of promising drug candidates. This is particularly important in therapeutic areas such as oncology, neurology, and infectious diseases, where time-to-market is critical. Advanced informatics tools are also supporting the growing trend of personalized medicine by facilitating genomic data analysis and biomarker discovery.

Additionally, the expansion of collaborative research models, strategic alliances between pharma and tech companies, and supportive government initiatives are accelerating market adoption. With rising healthcare demands, aging populations, and the push toward more efficient research processes, Drug Discovery Informatics is playing a central role in transforming drug development worldwide. Public-private partnerships and increased funding in biomedical innovation are also contributing to the robust growth of the Drug Discovery Informatics market.

Jubilant Pharma Limited., Certera., Thermo Fisher Scientific Inc., Dassault Systemes SE, Revvity Inc., Selvita., Eurofins Scientific SE., Collaborative Drug Discovery, Inc., and Charles River Laboratories International Inc are among the key global drug discovery informatics market players that are profiled in this market study.

The overall global drug discovery informatics market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the global drug discovery informatics market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the global drug discovery informatics market.

Product Code: TIPHE100000965

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Drug Discovery Informatics Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 Platform Providers & Technology Innovators:
- 4.3.2 Pharmaceutical & Biotechnology Companies:
- 4.3.3 Regulatory Agencies & Public-Private Partnerships:
- 4.3.4 List of Vendors in Value Chain

5. Drug Discovery Informatics Market - Key Market Dynamics

5.1 Drug Discovery Informatics Market - Key Market Dynamics
5.2 Drivers
- 5.2.1 Rise in Prevalence of Chronic Diseases
- 5.2.2 Advancements in Personalized Medicine
- 5.2.3 Surge in Government and Institutional Funding
5.3 Restraints
- 5.3.1 High Implementation and Licensing Costs
- 5.3.2 Shortage of Skilled Professionals
- 5.3.3 Data Privacy and Security Concerns
5.4 Opportunities
- 5.4.1 Increase in Adoption of Cloud-Based Solutions
- 5.4.2 Advancements in Genomics and Biotechnology
- 5.4.3 Rise in Demand for Biologics
5.5 Trends
- 5.5.1 Integration of Artificial Intelligence and Machine Learning
- 5.5.2 Adoption of Real-World Evidence (RWE) and Real-World Data (RWD)
- 5.5.3 Utilization of Automation and Robotics
5.6 Impact of Drivers and Restraints:

6. Drug Discovery Informatics Market - Global Market Analysis

6.1 Drug Discovery Informatics Market Revenue (US$ Million), 2021-2031
6.2 Drug Discovery Informatics Market Forecast Analysis

7. Drug Discovery Informatics Market Analysis - by Workflow

7.1 Discovery Informatics
- 7.1.1 Overview
- 7.1.2 Discovery Informatics: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Development
- 7.2.1 Overview
- 7.2.2 Drug Development: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)

8. Drug Discovery Informatics Market Analysis - by Service

8.1 Sequence Analysis Platform
- 8.1.1 Overview
- 8.1.2 Sequence Analysis Platform: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Molecular Modelling
- 8.2.1 Overview
- 8.2.2 Molecular Modelling: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Trial Data Management
- 8.3.1 Overview
- 8.3.2 Clinical Trial Data Management: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Docking
- 8.4.1 Overview
- 8.4.2 Docking: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)

9. Drug Discovery Informatics Market Analysis - by Solutions

9.1 Software
- 9.1.1 Overview
- 9.1.2 Software: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Services
- 9.2.1 Overview
- 9.2.2 Services: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)

10. Drug Discovery Informatics Market Analysis - by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Pharmaceutical and Biotechnology Companies: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
- 10.2.1 Overview
- 10.2.2 Contract Research Organizations (CROs): Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
- 10.3.1 Overview
- 10.3.2 Others: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)

11. Drug Discovery Informatics Market - Geographical Analysis

11.1 Overview
11.2 North America
- 11.2.1 North America Drug Discovery Informatics Market Overview
- 11.2.2 North America: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
- 11.2.3 North America: Drug Discovery Informatics Market Breakdown, by Workflow
  - 11.2.3.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
- 11.2.4 North America: Drug Discovery Informatics Market Breakdown, by Service
  - 11.2.4.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
- 11.2.5 North America: Drug Discovery Informatics Market Breakdown, by Solutions
  - 11.2.5.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
- 11.2.6 North America: Drug Discovery Informatics Market Breakdown, by End User
  - 11.2.6.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
- 11.2.7 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.2 United States: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.2.1 United States: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.2.7.2.2 United States: Drug Discovery Informatics Market Breakdown, by Service
    - 11.2.7.2.3 United States: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.2.7.2.4 United States: Drug Discovery Informatics Market Breakdown, by End User
  - 11.2.7.3 Canada: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.3.1 Canada: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.2.7.3.2 Canada: Drug Discovery Informatics Market Breakdown, by Service
    - 11.2.7.3.3 Canada: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.2.7.3.4 Canada: Drug Discovery Informatics Market Breakdown, by End User
  - 11.2.7.4 Mexico: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.4.1 Mexico: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.2.7.4.2 Mexico: Drug Discovery Informatics Market Breakdown, by Service
    - 11.2.7.4.3 Mexico: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.2.7.4.4 Mexico: Drug Discovery Informatics Market Breakdown, by End User
11.3 Europe
- 11.3.1 Europe Drug Discovery Informatics Market Overview
- 11.3.2 Europe: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
- 11.3.3 Europe: Drug Discovery Informatics Market Breakdown, by Workflow
  - 11.3.3.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
- 11.3.4 Europe: Drug Discovery Informatics Market Breakdown, by Service
  - 11.3.4.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
- 11.3.5 Europe: Drug Discovery Informatics Market Breakdown, by Solutions
  - 11.3.5.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
- 11.3.6 Europe: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.6.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
- 11.3.7 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.2 Germany: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.2.1 Germany: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.2.2 Germany: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.2.3 Germany: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.2.4 Germany: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.7.3 United Kingdom: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.3.1 United Kingdom: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.3.2 United Kingdom: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.3.3 United Kingdom: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.3.4 United Kingdom: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.7.4 France: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.4.1 France: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.4.2 France: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.4.3 France: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.4.4 France: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.7.5 Italy: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.5.1 Italy: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.5.2 Italy: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.5.3 Italy: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.5.4 Italy: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.7.6 Russia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.6.1 Russia: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.6.2 Russia: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.6.3 Russia: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.6.4 Russia: Drug Discovery Informatics Market Breakdown, by End User
  - 11.3.7.7 Rest of Europe: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.7.1 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.3.7.7.2 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Service
    - 11.3.7.7.3 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.3.7.7.4 Rest of Europe: Drug Discovery Informatics Market Breakdown, by End User
11.4 Asia Pacific
- 11.4.1 Asia Pacific Drug Discovery Informatics Market Overview
- 11.4.2 Asia Pacific: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
- 11.4.3 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Workflow
  - 11.4.3.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
- 11.4.4 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Service
  - 11.4.4.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
- 11.4.5 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Solutions
  - 11.4.5.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
- 11.4.6 Asia Pacific: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.6.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
- 11.4.7 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.2 China: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.2.1 China: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.2.2 China: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.2.3 China: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.2.4 China: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.7.3 Japan: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.3.1 Japan: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.3.2 Japan: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.3.3 Japan: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.3.4 Japan: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.7.4 India: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.4.1 India: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.4.2 India: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.4.3 India: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.4.4 India: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.7.5 Australia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.5.1 Australia: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.5.2 Australia: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.5.3 Australia: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.5.4 Australia: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.7.6 South Korea: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.6.1 South Korea: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.6.2 South Korea: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.6.3 South Korea: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.6.4 South Korea: Drug Discovery Informatics Market Breakdown, by End User
  - 11.4.7.7 Rest of APAC: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.7.1 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.4.7.7.2 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Service
    - 11.4.7.7.3 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.4.7.7.4 Rest of APAC: Drug Discovery Informatics Market Breakdown, by End User
11.5 Middle East and Africa
- 11.5.1 Middle East and Africa Drug Discovery Informatics Market Overview
- 11.5.2 Middle East and Africa: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
- 11.5.3 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
  - 11.5.3.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
- 11.5.4 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
  - 11.5.4.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
- 11.5.5 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
  - 11.5.5.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
- 11.5.6 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
  - 11.5.6.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
- 11.5.7 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.2 Arabia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.2.1 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.5.7.2.2 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Service
    - 11.5.7.2.3 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.5.7.2.4 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by End User
  - 11.5.7.3 South Africa: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.3.1 South Africa: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.5.7.3.2 South Africa: Drug Discovery Informatics Market Breakdown, by Service
    - 11.5.7.3.3 South Africa: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.5.7.3.4 South Africa: Drug Discovery Informatics Market Breakdown, by End User
  - 11.5.7.4 United Arab Emirates: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.4.1 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.5.7.4.2 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Service
    - 11.5.7.4.3 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.5.7.4.4 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by End User
  - 11.5.7.5 Rest of Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.5.1 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.5.7.5.2 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
    - 11.5.7.5.3 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.5.7.5.4 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
11.6 South and Central America
- 11.6.1 South and Central America Drug Discovery Informatics Market Overview
- 11.6.2 South and Central America: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
- 11.6.3 South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
  - 11.6.3.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
- 11.6.4 South and Central America: Drug Discovery Informatics Market Breakdown, by Service
  - 11.6.4.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
- 11.6.5 South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
  - 11.6.5.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
- 11.6.6 South and Central America: Drug Discovery Informatics Market Breakdown, by End User
  - 11.6.6.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
- 11.6.7 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.2 Brazil: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.2.1 Brazil: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.6.7.2.2 Brazil: Drug Discovery Informatics Market Breakdown, by Service
    - 11.6.7.2.3 Brazil: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.6.7.2.4 Brazil: Drug Discovery Informatics Market Breakdown, by End User
  - 11.6.7.3 Argentina: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.3.1 Argentina: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.6.7.3.2 Argentina: Drug Discovery Informatics Market Breakdown, by Service
    - 11.6.7.3.3 Argentina: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.6.7.3.4 Argentina: Drug Discovery Informatics Market Breakdown, by End User
  - 11.6.7.4 Rest of South and Central America: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.4.1 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
    - 11.6.7.4.2 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Service
    - 11.6.7.4.3 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
    - 11.6.7.4.4 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Product Development
13.4 Mergers & Acquisitions
13.5 Partnership and Collaboration
13.6 Expansion

14. Company Profiles

14.1 Jubilant Pharma Limited
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Certera
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dassault Systemes SE
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Revvity Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Selvita
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Eurofins Scientific SE
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Collaborative Drug Discovery, Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Charles River Laboratories International Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Illumina, Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 List of Abbreviations